Literature DB >> 23951821

Neonatal morbidity and mortality for repeated cesarean section vs. normal vaginal delivery to uncomplicated term pregnancies at Srinagarind Hospital.

Nootwadee Wankaew1, Junya Jirapradittha, Pakaphan Kiatchoosakun.   

Abstract

OBJECTIVE: To evaluate the morbidities and mortality of neonates delivered by elective repeated cesarean section vs. normal vaginal delivery among women with uncomplicated term pregnancies. MATERIAL AND
METHOD: A retrospective descriptive study was done between January 2009 and December 2011 to determine the morbidities and mortality among uncomplicated term pregnancies at Srinagarind Hospital. Three hundred seventy two neonates delivered by elective repeated cesarean section vs. 1,581 by normal vaginal delivery.
RESULTS: A significantly greater number of neonates in the elective repeated cesarean section group required oxygen for neonatal resuscitation compared to neonates in the normal vaginal delivery group (37.6% vs. 20.9%, p < 0.001). Neonates delivered by elective repeated cesarean section were more frequently admitted to the neonatal intensive care unit (1.1% vs. 0%, p < 0.001) and had longer hospital stays (4.56 +/- 2.45 vs. 4.07 +/- 1.44 days, p < 0.001). The latter not only had a higher rate of respiratory distress syndrome (0.8% vs. 0%, p < 0.001) and transient tachypnea of the newborn (3.2% vs. 0.3%, p < 0.001), which required more respiratory support, they also had a higher rate of infection (2.4% vs. 0.8%, p < 0.05) than neonates delivered by normal vaginal delivery. Neonates born by normal vaginal delivery, however had more birth trauma and hyperbilirubinemia than neonates born by elective repeated cesarean section (8.8% vs. 2.4%, p < 0.001 and 31.8% vs. 22.6%, p < 0.05, respectively). There was no difference in the mortality rate between the groups.
CONCLUSION: Even among uncomplicated term pregnancies, cesarean section is associated with more neonatal respiratory morbidity and sepsis while those delivered by normal vaginal delivery tend to have a higher rate of birth trauma and hyperbilirubinemia. Clinicians should therefore be concerned about the route of delivery and the probability of negative neonatal outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23951821

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

1.  Prenatal emotion management improves obstetric outcomes: a randomized control study.

Authors:  Jian Huang; He-Jiang Li; Jue Wang; Hong-Jing Mao; Wen-Ying Jiang; Hong Zhou; Shu-Lin Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  There is Only a Modest Increase in Neonatal Respiratory Morbidity Following Early Term Elective Cesarean in a South Indian Population.

Authors:  Nagaraja Katwa; Akhila Vasudeva; Leslie E S Lewis; Pratap Kumar
Journal:  J Obstet Gynaecol India       Date:  2017-04-25

3.  Restricted versus Standard Maintenance Fluid Volume in Management of Transient Tachypnea of Newborn: A Clinical Trial.

Authors:  Masoud Dehdashtian; Mohammad-Reza Aramesh; Arash Melekian; Mohammad-Hasan Aletayeb; Anahita Ghaemmaghami
Journal:  Iran J Pediatr       Date:  2014-10-01       Impact factor: 0.364

4.  Causes of death in children younger than five years in China in 2015: an updated analysis.

Authors:  Peige Song; Evropi Theodoratou; Xue Li; Li Liu; Yue Chu; Robert E Black; Harry Campbell; Igor Rudan; Kit Yee Chan
Journal:  J Glob Health       Date:  2016-12       Impact factor: 4.413

Review 5.  Different regimens of penicillin antibiotics given to women routinely for preventing infection after cesarean section: A systematic review and meta analysis.

Authors:  Dan Liu; Lingli Zhang; Chuan Zhang; Min Chen; Li Zhang; Jinke Li; Guanjian Liu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

6.  The risk factors and nursing countermeasures of sepsis after cesarean section: a retrospective analysis.

Authors:  Meiniang Shi; Lanlan Chen; Xiaoyun Ma; Biyu Wu
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-09       Impact factor: 3.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.